About Index Trending news
Analyze
Pricing
Epidarex Capital

Epidarex Capital

Work at Epidarex Capital? Add yourself to this profile

Epidarex Capital

Epidarex Capital (formerly Rock Spring Ventures) invests in earlystage, high growth life science and health technology companies in underventured markets within the UK and US.

Elsewhere

Alexa global traffic share

Activity

Past year's investments

Epidarex Capital participated in fewer than 3 rounds over the past year.

Latest rounds

- Eternygen GmbH: Venture capital (Series A) (€8M)
- Enterprise Therapeutics: Venture capital (£4M)
- mironid: Venture capital (Series A) ($6.2M)

Main Co-investors

- Gimv
- EMBL Ventures

Total funding
$4.8M in 1 rounds from 1 investors
By Epidarex Capital
$4.8M Series A in Dec, 2014
Total funding
$79.1M in 2 rounds from 7 investors
By Epidarex Capital
$47.1M Series D in Feb, 2016
Total funding
$15.2M in 1 rounds from 3 investors
By Epidarex Capital
€14M Series A in Mar, 2016
Total funding
$15.2M in 1 rounds from 4 investors
By Epidarex Capital
€14M Series A in Mar, 2016
Total funding
$6.2M in 1 rounds from 2 investors
By Epidarex Capital
$6.2M Series A in Jun, 2016
Total funding
$7.3M in 3 rounds from 4 investors
By Epidarex Capital
£4M Venture Capital in Nov, 2016
Total funding
$8.4M in 1 rounds from 3 investors
By Epidarex Capital
€8M Series A in Jan, 2017

Want to see the complete list?
Go Pro!